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Abstract. Agrin is thought to be the nerve-derived fac- 
tor that initiates acetylcholine receptor (AChR) clus- 
tering at the developing neuromuscular junction. We 
have investigated the signaling pathway in mouse C2 
myotubes and report that agrin induces a rapid but 
transient tyrosine phosphorylation of the AChR 13 sub- 
unit. As the 13-subunit tyrosine phosphorylation occurs 
before the formation of AChR clusters, it may serve as 
a precursor step in the clustering mechanism. Consis- 
tent with this, we observed that tyrosine phosphoryla- 
tion of the [3 subunit correlated precisely with the 
presence or absence of clustering under several experi- 
mental conditions. Moreover, two tyrosine kinase in- 
hibitors, herbimycin and staurosporine, that blocked 
B-subunit phosphorylation also blocked agrin-induced 
clustering. Surprisingly, the inhibitors also dispersed 
preformed AChR clusters, suggesting that the tyrosine 
phosphorylation of other proteins may be required for 
the maintenance of receptor clusters. These findings in- 
dicate that in mammalian muscle, agrin-induced AChR 
clustering occurs through a mechanism that requires ty- 
rosine phosphorylation and may involve tyrosine phos- 
phorylation of the AChR itself. 
T 
HE  accumulation  of  acetylcholine  receptors 
(AChR)  1 beneath the nerve terminal is one of the 
first discernible steps in synapse formation  at the 
neuromuscular junction (Hall and Sanes, 1993). The con- 
centration of AChRs in the postsynaptic muscle membrane 
is induced by the nerve and is due both to clustering of the 
preexisting  receptor and  to local insertion  of the newly 
synthesized receptor.  Agrin  is  thought  to be the nerve- 
derived factor that induces the initial  redistribution of the 
AChR (McMahan, 1990; Ferns and Hall, 1992), as well as 
the  accumulation  of several other  synaptic components 
(Wallace, 1989). Although agrin is expressed in embryonic 
muscle and in other nonneural tissues,  neurons synthesize 
a specific isoform of agrin, generated by alternative RNA 
splicing, that is significantly  more biologically active than 
the forms found in muscle (Ruegg et al., 1992; Tsim et al., 
1992; Ferns et al.,  1993; Hoch et al.,  1993). Neurally de- 
rived agrin is believed to cluster AChRs by acting on a 
specific  receptor  in  the  myotube  membrane.  Several 
groups have recently shown that the predominant  agrin- 
binding protein in muscle is et-dystroglycan  (Bowe et al., 
1994; Campanelli et al., 1994; Gee et al., 1994; Sugiyama et 
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al., 1994), a cell surface protein that is part of a transmem- 
brane  complex  of  proteins  associated  with  dystrophin. 
There is conflicting  data, however, as to whether ot-dystro- 
glycan is the signaling  receptor responsible for the initia- 
tion of AChR clusters, and other roles for the protein have 
been suggested (Sealock and Froehner, 1994; Sugiyama et 
al., 1994; Fallon and Hall, 1994). 
Although the receptor for agrin and its mode of signal- 
ing are not yet established, recent evidence suggests that 
tyrosine  phosphorylation  may  be  part  of the  signaling 
pathway, at least in chick muscle (Wallace et al., 1991; Qu 
and Huganir, 1994). Many growth and differentiation fac- 
tors  activate  receptor  or  cytoplasmic  tyrosine  kinases 
(Schlessinger  and  Ullrich,  1992; Kishimoto  et  al.,  1994) 
whose  phosphorylation  of specific  target  proteins  then 
regulates  protein-protein  interactions  that  form the sig- 
naling  cascade (Weiss and Littman,  1994). For example, 
tyrosine phosphorylation can result in the binding of other 
proteins via their SH2 domains, leading to the formation 
of signaling  complexes, or to the reorganization  of cyto- 
skeletal elements. Such a mechanism may be involved in 
the  agrin-induced  immobilization  and  clustering  of  the 
AChR. 
We have examined whether agrin-induced AChR clus- 
tering in mammalian muscle involves tyrosine phosphory- 
lation.  We  find  that  agrin  induces  a  transient  tyrosine 
phosphorylation of the AChR [3 subunit in mouse C2 myo- 
tube cultures.  Moreover, tyrosine  kinase  inhibitors  that 
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tering.  Our  results  indicate that  in  mammalian muscle, 
agrin-induced AChR clustering occurs through a mecha- 
nism that requires tyrosine phosphorylation and may in- 
volve tyrosine phosphorylation of the AChR itself. 
Materials and Methods 
Production of  Recombinant Agrin 
To produce recombinant agrin in soluble form, we expressed the COOH- 
terminal half of agrin isoforms by transfection in COS cells. We used both 
the most active, neural-specific isoform (C-Ag12,4,8), and the predominant 
muscle isoform (C-Ag12.0.0) (Ferns et al., 1993).  COS cells were transiently 
transfected by the DEAE-dextran method, as described previously (Ferns 
et al., 1993),  and the media containing the secreted agrin was collected. 
The concentration of agrin was determined using agrin immunoblots, by 
comparing samples of media to a known standard of purified agrin (Ferns 
et al., 1993). 
Assay of  Agrin-induced A ChR Clustering 
C2C12 mouse muscle cells, and the variant $26 and $27 lines, were cul- 
tured as previously described (Gordon and Hall, 1989).  All experiments 
were performed on 2-3-d-old myotubes grown on 8-well chamber slides 
(Lab-Tek; Miles Laboratories, Inc., NaperviUe, IL). Myotubes were incu- 
bated with neural agrin and stained for the AChR by incubating the live 
cells with rhodamine-conjugated ct-bungarotoxin for 1 h. The cells were 
then rinsed and fixed with 2% paraformaldehyde for 20 min. The levels of 
AChR clustering were compared by determining the average AChR clus- 
ter number in random fields, at a magnification of 400 with a fluorescent 
microscope (E. Leitz, Inc., Rockleigh, N J). 
Tyrosine Kinase Inhibitor Experiments 
We tested the ability of the following tyrosine kinase inhibitors to block 
agrin-induced AChR clustering: methyl 2,5-dihydroxycinnamate, laven- 
dustin A, 2-hydroxy-5-(2,5-dihydroxybenzyl) aminobenzoic acid, genistein, 
reduced  carboxamidomethylated and  maleylated  lysozyme, tyrphostin, 
herbimycin  A  (Gibco-BRL,  Gaithersburg,  MD),  and  staurosporine 
(Sigma Chemical Co., St. Louis, MO). Myotubes were preincubated with 
the inhibitors or a carrier control (DMSO) for 0.5-2 h, and then neural 
agrin was added at ~500 pM for a further 6-8 h. In separate experiments 
to examine whether the inhibitors dispersed preformed receptor dusters, 
myotubes were treated with neural agrin for 24 h, and then treated with the 
inhibitors for 6--8 h. After these agrin/inhibitor treatments, the myotubes 
were stained for the AChR, and the levels of AChR clustering were com- 
pared, as described above. All cultures were coded and counted blind. 
To costain for rapsyn (43-kD protein), after fixation the cells were per- 
meabilized in 1% Triton X-100 for 10 min, blocked with 10% horse se- 
rum/PBS, and incubated with the anti-rapsyn antibodies (rnAb 1234A and 
mAb 1579A, provided by S. Froehner) and then an FITC-labeled sheep 
anti-mouse second antibody. 
To confirm that the tyrosine kinase inhibitors were not having nonspe- 
cific effects, we assayed the level of surface AChR. Control and inhibitor- 
treated cultures were incubated with 10 nM 1125 ct-bungarotoxin in fusion 
medium for 2 h to specifically label the surface AChR. The cultures were 
then rinsed and extracted with 0.1 N NaOH, and the level of bound toxin 
was determined with a gamma counter. 
Extraction and Isolation of the A ChR 
To assay AChR subunit tyrosine phosphorylation, myotube cultures were 
treated with agrin/inhibitors, rinsed, scraped off in PBS Ca/Mg-free con- 
taining 1 mM sodium orthovanadate, and pelleted. The ceils were then ex- 
tracted in the following buffer containing 1% Triton X-100 (25 mM Tris, 
25 mM glycine, 150 mM NaC1, 5 mM EDTA, 5 mM EGTA, 50 mM NaF, 1 
mM sodium orthovanadate, and the protease inhibitors, PMSF, benzami- 
dine, N-ethylmaleimide, and Na2S406).  Insoluble material, such as nuclei 
and extracellular matrix, was removed by centrifugation at 18,000 g for 4 
min. The solubilized AChR was isolated by incubating the extracts with 
a-bungarotoxin conjugated to agarose beads. The proteins isolated on the 
beads were eluted in SDS loading buffer, separated by electrophoresis on 
10% polyacrylamide gels, and transferred to nitrocellulose membranes. 
The proteins were probed with a monoclonal antiphosphotyrosine anti- 
body (mAb 4G10), followed by an HRP-conjugated sheep anti-mouse 
second antibody, and then visualized using the enhanced chemilumines- 
cence method (ECL; Amersham Corp., Arlington Heights, IL). To  re- 
probe the blots, they were first stripped of antibodies by washing with a 
low pH buffer (200 mM glycine, 0.1% Tween 20, at pH 2.5 for 20 min). 
They were then reprobed  for the AChR subunits, both to identify the 
phosphotyrosine  immunoreactive  bands  and  to  confirm  that  equal 
amounts of AChR were present in all samples. The ct subunit was identi- 
fied using mAb 210, the 13 subunit using mAb 124, and the 5 subunit using 
mAb 88b (all gifts of J. Lindstrom, University of Pennsylvania, Philadel- 
phia, PA). The level of 13-subunit  phosphotyrosine immunoreactivity on 
blots was quantified with a  scanning spectrophotometer (Du-SB; Beck- 
man Instruments, Inc., Fullerton, CA). 
Results 
Agrin Induces a Transient Tyrosine Phosphorylation of 
the AChR fl Subunit 
The mechanism by which agrin induces AChR clustering 
in mammalian muscle is unclear (Qu et al., 1990). We have 
examined the possibility that aggregation is regulated by 
agrin-induced tyrosine phosphorylation of the AChR it- 
self. To address this question, we have taken advantage of 
a simplified system using C2 mouse myotubes and recom- 
binant isoforms of agrin. The myotubes were treated with 
a neural-specific isoform of agrin (C-Ag12.g,s; Ferns et al., 
1993), cell extracts were prepared, and the AChR was par- 
tially purified using et-bungarotoxin conjugated to agarose 
beads. The isolates were separated by PAGE and immu- 
noblotted with an  antiphosphotyrosine antibody (4G10). 
Phosphotyrosine-immunoreactive bands  were  identified 
on the basis of size and by reprobing with AChR subunit- 
specific antibodies. 
We find that agrin treatment induces a rapid but tran- 
sient tyrosine phosphorylation of the 13 subunit (Fig. 1). In 
untreated myotube cultures, there was a low, or often un- 
detectable,  level of [3-subunit  tyrosine phosphorylation. 
After  treatment  with  neural  agrin  (100  pM),  however, 
there was a dramatic increase of phosphorylation that was 
evident by 15 min, peaked between.1 and 3 h, and then de- 
clined. By 8 h, the level of tyrosine phosphorylation was at 
36% of peak level, and by 24 h the level approached, but 
was still slightly above (7%) that seen in the control cul- 
tures (0.5 %). In addition, the time course of tyrosine phos- 
phorylation is considerably offset from that of AChR clus- 
tering (Fig.  1 B).  Receptor  clusters only begin  to form 
after 2-4 h of agrin treatment and peak in number at 6--8 h. 
Cluster number then declines slightly, although this ap- 
pears to be due to the coalescence of small clusters. Agrin- 
induced  13-subunit  phosphorylation  therefore  begins  at 
least 2 h before the first detectable stages of AChR clus- 
tering. Similarly, the peak of phosphorylation occurs be- 
fore discernible receptor dusters form, and well before the 
peak of cluster number at 6-8 h  (Fig. 1 B). Phosphoryla- 
tion of the 1~ subunit thus may be an early, precursor step 
in the signaling pathway that leads to clustering. 
We did not detect agrin-induced tyrosine phosphoryla- 
tion of the other AChR subunits or of coimmunoprecipi- 
tating proteins. Agrin-induced tyrosine phosphorylation of 
the 5 subunit has been seen in chick, and is reported to be 
sensitive to degradation during boiling in SDS loading buffer 
(Qu  and  Huganir,  1994). Even  using  unboiled  samples, 
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Figure 1.  (A) Agrin induces a transient tyrosine phosphorylation of the AChR 13 subunit. AChR from C2 cultures  treated with neural 
agrin (100 pM) over a range of times was isolated on ~t-bungarotoxin beads and immunoblotted with an antiphosphotyrosine antibody. 
Agrin induces a transient increase in tyrosine phosphorylation of a 49-kD band. Reblotting with the anti-13-subunit antibody (mAb 124) 
confirmed that the phosphotyrosine immunoreactive band corresponds to the t3 subunit,  and that equal amounts of the AChR are 
present in each lane. (B) Time course of agrin-induced  13-subunit phosphorylation and AChR clustering. The level of phosphotyrosine 
immunoreactivity for the 13 subunit  was quantified  over an agrin time course and is shown averaged from four experiments.  Agrin in- 
duces a pronounced and rapid increase in tyrosine phosphorylation, which peaks at 1-2 h. The increase is transient,  however, and has 
decreased to 36% of peak at 8 h, and 7% by 24 h. This contrasts with the time course of AChR clustering, where clusters first form at 
2-4 h and peak in number at 6--8 h. 
however, we found no evidence for phosphotyrosine bands 
matching those of the mouse ~ subunit, which we identi- 
fied by immunoblotting with a subunit-specific mAb (88b). 
Tyrosine Phosphorylation  of the [3 Subunit Correlates 
with A ChR Clustering 
To determine how closely 13-subunit  phosphorylation cor- 
relates with receptor clustering, we examined the extent of 
phosphorylation as a function of agrin concentration. Sets 
of myotube cultures were treated with concentrations  of 
neural agrin ranging from 1 pM to 333 pM, and assayed ei- 
ther for 13-subunit  phosphorylation or for receptor cluster- 
ing.  An  agrin-induced  increase  in  the  level of 13-subunit 
phosphorylation  was  first  observed  at  1-3  pM,  and  in- 
creased with agrin concentration  up to 333 pM, at which 
point  it  appeared to  plateau  (Fig.  2).  As  previously ob- 
served, increased AChR clustering was first observed with 
1-10 pM agrin and continued to increase until a level of 
1 nM. The concentration range over which agrin induces 
AChR  phosphorylation  thus  closely  matches  that  over 
which it induces AChR clusters. 
Similarly, we examined the action of the predominant mus- 
cle isoform of agrin (C-Ag12,0,0) on clustering and 13-subunit 
phosphorylation.  Muscle  agrin  only  differs  from  neural 
agrin in that it lacks two splicing inserts of four and eight 
amino acids, but it has been found to be >10,000-fold less 
active  in  AChR  clustering  (Ferns  et  al.,  1993).  Muscle 
agrin  also  fails  to  block  neural  agrin-induced  clustering 
(Bowen, D.C., J. Sugiyama, M. Ferns, and Z.W. Hall, manu- 
script submitted for publication). Consistent with these ob- 
servations, we find that muscle agrin did not induce 13-sub- 
unit phosphorylation, even at concentrations up to 10 nM 
(Fig.  3 A),  and  also failed to induce  receptor clustering. 
This finding thus further suggests that the signaling recep- 
tor is highly specific for the neural agrin isoform. 
Finally, we examined agrin signaling in two genetic vari- 
ants of C2 cells that are defective in their ability to cluster 
AChRs (Gordon and Hall, 1989; Gordon et al., 1993). The 
$26  and  $27  variants  have distinct  defects in  their  pro- 
teoglycans,  but  both  show  significantly  reduced  AChR 
clustering when treated with agrin (Ferns et al., 1993). In 
both $26 and $27 myotubes, we found that neural agrin, 
even at a concentration of 100 nM, failed to induce AChR 
13-subunit  phosphorylation  as  well  as  AChR  clustering 
(Fig. 3 B). Moreover, no basal level of 13-subunit phosphor- 
ylation was detectable in control $26 and $27 cultures, as is 
sometimes seen in C2 myotubes. Thus, under a variety of 
experimental conditions, agrin-induced receptor clustering 
parallels 13-subunit phosphorylation. 
Tyrosine Kinase Inhibitors Block fl-subunit 
Phosphorylation and A ChR Clustering 
To examine whether  13-subunit  tyrosine phosphorylation 
plays  a  critical  role  in  the  agrin  signaling  pathway,  we 
tested  whether  tyrosine  kinase  inhibitors  could  block 
phosphorylation  and  receptor  clustering.  As  previously 
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Figure 2.  13-subunit  tyrosine phosphorylation  correlates with agrin concentration.  (A) Phosphotyrosine  immunoblot of AChR from myo- 
tubes cultures treated with neural agrin at concentrations ranging from i pM to 333 pM. (B) The level of phosphotyrosine immunoreac- 
tivity for the 13 subunit  (E]), and the number of AChR clusters (O), were quantified  over the agrin concentration range. Agrin first in- 
creases 13-subunit phosphorylation at a concentration of 1-3 pM and approaches maximal phosphorylation from 33 to 100 pM. The level 
of phosphorylation correlates closely with the relative level of AChR clustering induced by agrin at those concentrations.  (The receptor 
clustering data is taken from Bowen, D.C., J. Sugiyama, M. Ferns,  and Z.W. Hall, manuscript submitted for publication,  and was ob- 
tained using the same batch of recombinant agrin). 
described,  treatment of myotubes with a  soluble form of 
recombinant neural  agrin induces  a  dramatic increase in 
the number of AChR clusters over a 6-8-h period (Fig. 4, 
A  and B) (Fems et al., 1993). Two tyrosine kinase inhibi- 
tors, herbimycin A  and staurosporine, efficiently blocked 
agrin-induced clustering of receptor (Fig. 4, C and D). Sev- 
eral other tyrosine kinase inhibitors that were tested (see 
Materials  and Methods)  had  no  effect.  Herbimycin  and 
staurosporine blocked agrin-induced clustering in a  dose- 
dependent manner (Fig. 5). The 9-11-fold increase in the 
number  of  AChR  clusters  induced  by  agrin  was  com- 
pletely inhibited by herbimycin and staurosporine, at con- 
centrations  of 0.5  ~M and 5  nM,  respectively. These re- 
sults  suggest  that  the  agrin  signaling  pathway  in  mouse 
muscle requires tyrosine phosphorylation. 
Moreover, we  found that  treatment  of myotubes with 
herbimycin and  staurosporine  completely blocked agrin- 
induced tyrosine phosphorylation of the 13 subunit. After a 
6-h preincubation, both inhibitors blocked the initial peak 
of  13-subunit  tyrosine  phosphorylation  seen  after  1  h  of 
agrin treatment (Fig. 6). Similarly, the phosphorylation re- 
maining after 6 h  of agrin treatment, when receptor clus- 
ters have formed, was absent in the presence of the inhibi- 
tors (Fig. 6). As 13-subunit  phosphorylation is blocked by 
the  inhibitors  that  block AChR  clustering,  AChR  phos- 
phorylation  could  be  a  necessary  step  in  the  clustering 
mechanism. 
Several lines of evidence indicate that the inhibition is 
not due to a  nonspecific, toxic effect on the cells. To ob- 
serve the effect on AChR clustering, myotubes were treated 
with the inhibitors and agrin for the shortest time possible 
(6-8 h) to avoid toxicity due to long-term exposure. After 
both  herbimycin  and  staurosporine  treatment,  myotube 
morphology was normal (Fig. 4, C and D), and spontane- 
ous contraction of myotubes was sometimes observed, as 
with untreated C2 myotubes, indicating that the health of 
the  cells  was  not  significantly  compromised.  Consistent 
with this, the inhibitors  did not  affect AChR number, as 
assayed by binding of ~25I ot-bungarotoxin. Surface levels 
of receptor were equivalent for the carrier control (84 _+ 4 
cpm/Izg protein  [mean _  SEM])  and for the herbimycin- 
(83 -+ 9) and staurosporine-treated cultures (86 -  7). Fur- 
thermore, treated myotubes were able to recover when the 
inhibitors were removed and to subsequently cluster recep- 
tors in response to agrin (data not shown). Finally, some of 
the  other inhibitors  that  were  tested did  affect myotube 
morphology, but did not block receptor clustering. 
In double-labeling experiments, we  also examined the 
effect of each inhibitor on the distribution of rapsyn, a cy- 
toplasmic peripheral  membrane protein  that  is  precisely 
codistributed with the AChR in clusters. In all of our ex- 
periments,  clusters  of the  AChR  were  always accompa- 
nied by rapsyn and vice versa. Thus, the inhibitors acted to 
prevent or disperse the clustering of both proteins in con- 
cert (data not shown). 
Finally, we tested the effect of herbimycin and stauro- 
sporine treatment on preformed clusters. Surprisingly, we 
found that receptor clusters that had been induced by 1-2-d 
agrin  treatment  were  completely  dispersed  after  6-8-h 
treatment with  herbimycin and  staurosporine  at concen- 
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lation. Phosphotyrosine  immunoblot of AChR from C2 myotube 
cultures treated with muscle agrin (C-Ag0,0). Muscle agrin, even 
at a concentration of 10 nM, did not induce B-subunit phosphory- 
lation. (B) Neural agrin fails to induce 13-subunit  phosphorylation 
in $26 myotubes.  Phosphotyrosine  immunoblot  of AChR from 
$26 myotubes treated with neural  agrin (C-Ag4.s). Neural agrin 
did not increase 13 phosphorylation when added at concentrations 
that do not induce receptor clustering (e.g., up to 100 nM). 
trations  of over 1  ~M  and  10 nM,  respectively (Fig.  7). 
These results suggest that tyrosine phosphorylation is re- 
quired not only for the formation but also for the stability 
and maintenance of agrin-induced AChR clusters. 
Discussion 
We have investigated the agrin signaling pathway in mam- 
malian muscle and find that it involves tyrosine phosphor- 
ylation of the AChR itself. Neural agrin induces a  rapid 
but  transient  tyrosine  phosphorylation  of the  AChR 
subunit.  Interestingly,  [~-subunit  phosphorylation  begins 
over 2 h before the first discernible receptor clusters form 
and peaks 4-6 h before the peak in AChR cluster number. 
In fact, the level of tyrosine phosphorylation is in marked 
decline at precisely the time that cluster number is increas- 
ing towards  its peak.  Tyrosine phosphorylation of the  [3 
subunit therefore appears to be lost upon receptor aggre- 
gation. The transient nature of the phosphorylation pro- 
vides an explanation as to why previous studies in rat and 
mouse have not observed tyrosine phosphorylation in as- 
sociation with  developing receptor clusters, nor tyrosine 
phosphorylation  of the  AChR  until  1-2  wk  postnatally 
(Qu et al., 1990; Campanelli et al., 1993). 
Studies in chick muscle have also shown that purified 
agrin, of unknown isoform, induces a rapid tyrosine phos- 
phorylation of the AChR i3 subunit (Wallace et al., 1991). 
The phosphorylation is not lost with receptor aggregation, 
however, and in contrast to mouse muscle, the developing 
clusters stain with antiphosphotyrosine antibodies. A  fur- 
ther  difference is  that  in  chick  muscle,  innervation and 
agrin also induce tyrosine phosphorylation of the 8 subunit 
(Qu and Huganir, 1994). Despite careful examination, we 
did not detect ~-subunit tyrosine phosphorylation in  C2 
mouse myotubes. Our results therefore extend on the find- 
ings  made  in  chick  and  suggest  that  the  agrin-induced 
phosphorylation of the  13  subunit  is  an  early, precursor 
step  to  aggregation,  rather  than  being  involved  in  the 
maintenance of clusters. 
Several observations point to  agrin-induced  13-subunit 
phosphorylation being a critical element in the clustering 
pathway. First, we observe a precise correlation between 
the extent of 13-subunit  phosphorylation and the level of 
receptor clustering seen over a  wide range of concentra- 
tions of neural agrin. Second, muscle agrin, which is 10,000- 
fold less active in inducing receptor clustering than neural 
agrin,  did  not  induce  13-subunit  phosphorylation.  Third, 
neural agrin did not induce 15-subunit phosphorylation in 
two  proteoglycan mutants  that  have  a  significantly  re- 
duced clustering response to agrin. Under several different 
experimental conditions, therefore, the extent of [3-subunit 
tyrosine phosphorylation is correlated with the presence 
or absence of receptor clustering. 
Finally, and most importantly, agrin-induced [5-subunit 
phosphorylation is completely blocked by the inhibitors, 
herbimycin and staurosporine. As these tyrosine kinase in- 
hibitors also block receptor clustering, phosphorylation of 
the AChR may thus be a  required step for aggregation. 
Both herbimycin and staurosporine blocked receptor clus- 
tering in a  dose-dependent manner, and several controls 
and observations confirm that the block by the inhibitors 
was not a nonspecific or toxic effect. Treatment with the 
inhibitors did not adversely affect myotube morphology, 
contractile activity, or levels of surface AChR. Moreover, 
after removal of inhibitor, the myotubes were able to re- 
cover and form agrin-induced AChR clusters. Our results 
thus  strengthen  the  finding  in  chick  muscle  that  both 
AChR clustering and [5-subunit tyrosine phosphorylation 
are blocked by staurosporine (Wallace, 1994). 
A direct test of the role of [5-subunit tyrosine phospt Jr- 
ylation in clustering has been made using a nonmu~cl ~. c~ll 
system.  When  rapsyn is  coexpressed with  the  ACh2  in 
nonmuscle cells, it induces the formation of small receptor 
aggregates (Froehner et al., 1990; Phillips et al., 1991). Mu- 
tation of the relevant tyrosine in the [3-subunit  intracellu- 
lar loop (Wagner et al., 1991; Huganir and Miles, 1989) did 
not prevent this aggregation (Yu and Hall, 1994). The rap- 
syn-induced clustering in nonmuscle cells, however, may 
not accurately reflect the regulated clustering that occurs 
in myotubes. First, tyrosine kinase inhibitors fail to block 
the  AChR/rapsyn  aggregation in  COS  cells  (Taylor, R., 
and Z. Hall, unpublished observations). Second, in nonin- 
nervated muscle cells rapsyn and the AChR do not nor- 
mally form a significant number of spontaneous receptor 
clusters, but are diffusely distributed at the cell surface. 
Thus, experiments in muscle cells will be required to de- 
Ferns et al. Agrin-induced AChR Clustering  941 Figure 4.  Inhibition of agrin-induced AChR clustering by herbimycin and staurosporine. C2 myotubes either were untreated (A), or 
were treated with agrin in the presence of a carrier control (B), 1 t~M herbimycin (C), or 10 nM staurosporine (D). Cultures were 
stained with rhodamine-conjugated e~-bungarotoxin to assay receptor clustering.  Herbimycin and staurosporine both completely inhib- 
ited agrin-induced AChR clustering.  Bar, 10 Ixm. 
termine if 13-subunit phosphorylation is required for agrin- 
induced clustering of the AChR. 
The  agrin-induced  tyrosine  phosphorylation  of  the  13 
subunit  and the effect of the inhibitors  suggests  that  the 
agrin signaling pathway in mammalian muscle involves ac- 
tivation of tyrosine kinases. Potentially, the pathway could 
require a receptor tyrosine kinase activated by agrin bind- 
ing, a cytoplasmic tyrosine kinase associated with a nonki- 
nase  receptor,  or a  kinase  involved in a  downstream  sig- 
naling event. As the known specificities of the two effective 
Figure 5.  Dose dependence of inhibition  of 
clustering by herbimycin and staurosporine. 
The number of AChR clusters per field  was 
determined for myotube cultures treated with 
agrin alone or with agrin in the presence of a 
range  of concentrations  of herbimycin  and 
staurosporine. Agrin alone induced a 10-fold 
increase in the number of receptor clusters. 
The  increase  in clustering  was  inhibited  by 
both herbimycin and staurosporine in a dose- 
dependent manner. 
The Journal of Cell Biology,  Volume 132, 1996  942 Figure 6.  Agrin-induced  13-subunit phosphorylation is blocked by 
herbimycin and staurosporine. Phosphotyrosine immunoblot of 
AChR  from myotube cultures  treated  with  a  carrier control, 
agrin alone (100 pM), or agrin in the presence of 1 ~M herbimy- 
cin  or  10  nM  staurosporine.  The  agrin-induced  increase  in  13 
phosphorylation is blocked by both inhibitors,  under the same 
conditions in which they block agrin-induced  AChR clustering. 
inhibitors differ, the identity of the critical kinase(s) is un- 
clear. Herbimycin is reported to be a relatively specific in- 
hibitor  of protein  tyrosine  kinases,  especially of the  src 
family.  Staurosporine  is  less  specific,  however,  and  is 
known to inhibit not only some receptor tyrosine kinases, 
but also protein kinase C and cyclic nucleotide-dependent 
kinases. Another possibility is that the two inhibitors may 
not act on the same kinase, but may affect distinct kinases 
at different points in the signaling pathway. 
Agrin signaling may well involve tyrosine phosphoryla- 
tion of proteins in addition to the AChR. Consistent with 
this possibility, the  maintenance  of receptor clusters was 
found to be dependent on tyrosine phosphorylation, even 
though [3-subunit phosphorylation is lost by that time and 
is unlikely to be involved. The ability of herbimycin and 
staurosporine both to block cluster formation and to dis- 
perse clusters suggests that the same tyrosine kinase may 
be involved in each case. One possibility is that an inhibi- 
tor-sensitive kinase phosphorylates the [3 subunit and is re- 
cruited  to  clusters  along with  the  AChR,  where  it  may 
then act on other proteins. A  number of proteins that are 
concentrated  at  the  neuromuscular  junction  contain  ty- 
rosine  phosphorylation  consensus  sites,  or  have  been 
shown to be tyrosine phosphorylated in Torpedo electric 
organ. These include integral membrane proteins ([3-dys- 
troglycan  [Ibraghimov-Beskrovnaya et  al.,  1992]),  mem- 
brane-associated proteins  (rapsyn and the 58-kD protein 
[Froehner, 1991; Adams et al., 1993]), and cytoskeletal ele- 
Figure 7.  Dispersal of preformed AChR clusters  by herbimycin 
and staurosporine.  Myotube cultures  that had been previously 
treated with agrin to induce AChR clusters were treated with a 
carrier control (A), 2 ~M herbimycin (B), or 20 nM staurosporine 
(C). Preformed dusters were dispersed by both inhibitors after 6--8  h. 
Bar, 10 ~m. 
ments (the 87-kD protein and paxillin [Wagner et al., 1993; 
Gumbiner, 1993]).  Agrin-induced phosphorylation of such 
proteins  may  also  be  required  for  cluster  formation  or 
maintenance. 
Given the  complexity of the  postsynaptic structure,  it 
seems likely that the agrin signaling pathway governing its 
Ferns et al. Agrin-induced AChR Clustering  943 assembly will be complex and will involve regulatory steps 
in addition to tyrosine phosphorylation. This is supported 
by the fact that clustering can be blocked not only by ty- 
rosine kinase inhibitors, but also by phorbol esters, which 
activate protein kinase  C  (Wallace  et al.,  1991),  and by 
orthovanadate, a phosphatase inhibitor.  Orthovanadate is 
interesting in that it increases the level of 13-subunit phos- 
phorylation, yet  blocks  agrin-induced  clustering in  both 
chick  (Wallace,  1995)  and  mouse myotubes  (Ferns  and 
Hall,  1992)  (data  not  shown).  Thus,  13-subunit tyrosine 
phosphorylation is not sufficient, in itself, to produce clus- 
tering of receptor.  Clearly  a coordinated interplay of ty- 
rosine kinase and phosphatase activity  is required for ag- 
gregation. 
Overall,  our  findings  provide  strong  correlative  evi- 
dence  linking  13-subunit phosphorylation  and  receptor 
clustering.  Our  findings  suggest  the  following  general 
model for agrin-induced receptor clustering.  In uninner- 
vated muscle, the AChR is diffusely distributed and is not 
tyrosine phosphorylated. Upon innervation, neural agrin 
binds its receptor, inducing the activation of tyrosine ki- 
nases  that phosphorylate  the  AChR  and possibly other 
proteins. Tyrosine phosphorylation then regulates the as- 
sociation of the AChR with proteins that link it to the cy- 
toskeleton and result in its recruitment into clusters. These 
proteins may include the utrophin-associated complex. Af- 
ter aggregation, tyrosine phosphorylation of the AChR is 
lost in mammalian muscle, but the tyrosine phosphoryla- 
tion of other proteins required for the further develop- 
ment and maintenance of clusters is maintained. An im- 
portant future area of interest will be to define the protein 
interactions of the AChR that are regulated by tyrosine 
phosphorylation. 
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